Operating Segments (Tables)

3 Months Ended

Dec. 31, 2012

Segment Revenue, Operating Income from Continuing Operations and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, as follows (in thousands):

	Three months ended December 31,
	2012			2011
Revenue:
Medical Device	$	10,531		$	8,867
In Vitro Diagnostics		3,320			3,049
Total revenue	$	13,851		$	11,916
Operating income (loss):
Medical Device	$	5,840		$	3,932
In Vitro Diagnostics		751			906
Corporate		(1,714	)		(1,616	)
Total operating income from continuing operations	$	4,877		$	3,222
Depreciation and amortization:
Medical Device	$	317		$	364
In Vitro Diagnostics		215			195
Corporate		190			190
Total depreciation and amortization	$	722		$	749